AmeriServ Financial, Inc. (ASRV)

Verve Therapeutics Revenue

AmeriServ Financial had revenue of $11.36M in the quarter ending June 30, 2025, a decrease of -11.36%. This brings the company's revenue in the last twelve months to $51.58M, up 13.95% year-over-year. In the year 2024, AmeriServ Financial had annual revenue of $53.14M with 18.14% growth.

• Revenue (ttm): $51.58M
• Revenue Growth: +13.95%
• P/S Ratio: 0.94
• Revenue / Employee: $164,796
• Employees: 313
• Market Cap: 48.40M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.14M	8.16M	18.14%
Dec 31, 2023	44.98M	-12.23M	-21.37%
Dec 31, 2022	57.21M	1.46M	2.62%
Dec 31, 2021	55.74M	5.48M	10.90%
Dec 31, 2020	50.27M	852.00K	1.72%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.